Browse By: Country ι Category ι Tag

Hepatitis - Pipeline Review, H2 2012

Pages » 356
Published By » Global Markets Direct
Price » $2500
In stock
View Report Details
Description

Hepatitis Pipeline Review, H2 2012 Global Markets Directs, 'Hepatitis Pipeline Review, H2 2012', provides an overview of the Hepatitis therapeutic pipeline. This report provides information on the therapeutic development for Hepatitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hepatitis. 'Hepatitis Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific thi... Click here for more details


 


 

Related News

Samsung Galaxy Note 8 Camera Hardware Leaked
Samsung seemingly is set to pursue the trend of using a dual camera system for its smartphone, the upcoming and most awaited- Samsung Galaxy Note 8. The recent leaked details of the rear casing of this phablet reveal the use of twin-shooter camera approach. So as to maintain its reputation, Samsung needs to use new technology and dual cameras are the new black! Samsung’s S8 and S8 Plus have both pushed the limits of single lens shooting technology and are have made it to the top list of best s
Date: Jun 22

Autoimmunity May Play a Part In Parkinson’s Disease
A new evidence found by scientists from Columbia University Medical Center in New York City, NY, and the La Jolla Institute for Allergy and Immunology in California states that autoimmunity could play a part in Parkinson’s disease. Fragments of the protein have been found that has built up in the dopamine cells present in the brain of people suffering from Parkinson's disease. These proteins trigger an immune response and have the ability to kill the cells. The study states that there may
Date: Jun 22

Synthetic Genomic and ExxonMobil Joint Efforts Pave Way to Achievable Algae-based Renewable Energy
A recent press release has announced that the partnership between ExxonMobil and Synthetic Genomics has led to the development of a modified strain of algae that is expected to bring the concept of algae-based energy a step closer to being a commercially viable source of alternate energy. Researchers have long projected that the only way that algae-based energy has a commercial future is a high content algae strain that can quickly grow is developed or discovered. Strain with Massive Rise in Oi
Date: Jun 21

China Province to Set Renewable Energy Record
Qinghai province in China is all set to make a new record by cutting its carbon emissions to null, powering the entire province by renewable energy for a course of seven weeks as a trial. The province, with a population of 5.8 mn, started observing the complete reliance on renewable energy from June 17 and will continue to do so until the 23rd of the month. Set to Break Portugal’s Four-day Record The province is mainly focusing on sustaining on clean energy sources such as solar power, wind
Date: Jun 21

Facebook takes Stern Steps for Removing Terrorist Content
Lately, Facebook has been criticized a lot for not taking proper measures in order to eliminate terrorist content from their website. A lot of activities have spurred up that are illegal and related to terrorist activities, in Facebook. Thus, to address these issues, Facebook has recently unveiled that it will take and is one the verge of taking serious and noteworthy steps for eliminating the contents from the social media site that has terror related links. The move is said to have risen after
Date: Jun 19

Corporate Groups Gather for Lenient ‘Brexit’ as Negotiations Begin
After the final call for Brexit and with the start of negotiations between the United Kingdom and the EU in Brussels, business associations of the Kingdom have come together to ask for a softer and lenient Brexit as David Davis, Brexit Secretary takes his step forth. The negotiation is being called as a “divorce bill” of the UK. Mr. David said that the deal is one of its kind in history and he is looking forward to a special and deep partnership. By the end of March 2019, the UK is set to le
Date: Jun 19

Sony’s Abuse of Dominance of PS4 could Create Problems for Gaming Industry
Sony’s dominance in the gaming console industry at present is unquestioned. Despite the growing popularity of Xbox consoles and the sales boost likely to be provided by the recent announcement of the excellent Xbox One X, Sony’s PS4 and PS4 Pro have been ruling the roost in the gaming industry for a few years. Sony’s slightly underwhelming show at the 2017 E3 was also revealing in that Sony didn’t really need to ramp up their efforts to highlight the advantages of the PS4 range over Micr
Date: Jun 15

Obama Administration’s Rules against Abuse by For-profit College Delayed
Education Secretary Betsy DeVos announced on Wednesday that two key rules aimed at limiting the harm caused by fraudulent for-profit colleges are being delayed, potentially with a view to abandoning them altogether. The rules comprised a crucial part of President Obama’s crackdown on for-profit colleges intended to secure the futures of citizens having their career prospects hampered by fraudulent activities. What are the Rules in Question? The two rules dealt with erasing the federal loan d
Date: Jun 15

Microsoft to Take on Sony’s PlayStation with Xbox One X
Microsoft introduced Xbox One X on Sunday, June 11, 2017. According to the technology giant, it is the most powerful video console made ever. With this, Microsoft aims to take on Sony’s PlayStation, the reigning king of the market. Phil Spencer, the Xbox team leader, said that the video console, priced at a hefty US$499 and built with a muscle for a seamless game on ultra-high-definition (UHD) televisions will be available to be sold across the world by November 09, 2017. The much-anticipated
Date: Jun 14

Goodera Bags US$5.5 mn in Series-A Funding from Omidyar Network and Nexus Venture Partners
Goodera, a global corporate social responsibility (CSR) and sustainability platform that connects enterprises with non-profit organization bags US$5.5 mn from Omidyar Network and Nexus Venture Partners in a series-A funding. Formerly known as NextGen, the company plans to utilize this investment to strengthen its product portfolio and boost its expansion in the U.S. and India. On Goodera’s platform, enterprises and non-profit organizations can have complete visibility over both, the developme
Date: Jun 14

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency
Price: $5795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency
Price: $5795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency
Price: $5795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency
Price: $5795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency
Price: $5795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency
Price: $5795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency
Price: $5795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency
Price: $5795
Personalized Medicines Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The US market for personalized medicines is predicted to grow at the compounded annual growth rate of 9.5% during 2010 to 2015. This growth in future is expected to be driven by different factors like cost savings on treatments, early diagnosis of disease, drug safety, patient compliance, and opti
Published By: Transparency
Price: $5795
Neurometabolic Disorder Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
A Neurometabolic disorder is a group of individually rare and progressive disorders limited to symptomatic patient care. The analytical and clinical research result predicts significant development in explaining the molecular genetics, biochemical irregularities, pathogenesis of this disorder an
Published By: Transparency
Price: $5795